Mechanistic studies showed that EDN1 may promote myocardial inflammation by activating the NF-κB pathway, suggesting that EDN1 may serve as a potential biomarker of the immune microenvironment in DCM. The gene discussed is EDN1; the disease is familial dilated cardiomyopathy.